MedTrace Logo

Effectiveness of a Structured Intervention to Optimize the Use of Mirabegron

NCT03536494 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1932

Last updated 2018-11-07

No results posted yet for this study

Summary

This study was a multicentre, quasi-experimental design, controlled, before-and-after trial to estimate the effectiveness related to the review of mirabegron use and, if appropriate, its discontinuation.

Intervention group: Patients with mirabegron prescription assigned to any of the 17 primary health care centers (PHC) located in the northern area of Barcelona.

Control group: All the other patients assigned to any of the other 34 health care centers in Barcelona belonging to the Catalan Institut of Health (CIH).

The structured intervention included initiatives with general practitioners and urologists/gynaecologists, management support from health care authorities, and monthly feed-back monitoring to general practitioners (GPs).

The follow-up period was 12 months, from January 1st to December 31st, 2017.

Conditions

  • Overactive Bladder Syndrome

Interventions

BEHAVIORAL

Review the use of mirabegron and its discontinuation

A structured intervention was designed consisting of four major sections: * General practitioners: information and training with written material and patient-centred prescribing. * Specialized hospital care: information regarding the intervention for urologists and gynaecologists. * Management support with the definition of a structured strategy. * Monthly monitoring of the intervention.

Sponsors & Collaborators

  • Catalan Institute of Health

    lead OTHER_GOV

Principal Investigators

  • Eladio Fernández-Liz, PhD · Pharmacist

  • Pedro Vivó Tristante, Physician · Director. Primary Health Care Center Montcada i Reixac

  • Antonio Aranzana Martínez, Physician · Director. Primary Health Care Center Rio de Janeiro

  • Mª Estrella Barceló Colomer, Physician · Clinical Pharmacologist

  • José Ossó Rebull, Physician · Director. Primary Health Care Center Sant Andreu

  • María José López-Dolcet, Physician · Director. Primary Health Care Center Service Muntanya

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2017-12-31
Completion
2017-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03536494 on ClinicalTrials.gov